A Case of Pompholyx after Intravenous Immunoglobulin Therapy.
- Author:
Seo Rye YOO
1
;
Ji Goo OH
;
Young Suck RO
Author Information
1. Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea. romio@hanyang.ac.kr
- Publication Type:Case Report
- Keywords:
Intravenous immunoglobulin;
Pompholyx
- MeSH:
Alopecia;
Anaphylaxis;
Blister;
Dermatitis;
Dermatology;
Dermatomyositis;
Eczema;
Eczema, Dyshidrotic*;
Graft vs Host Disease;
Humans;
Immunization, Passive*;
Immunoglobulins*;
Meningitis, Aseptic;
Middle Aged;
Necrosis;
Pruritus;
Skin;
Urticaria
- From:Korean Journal of Dermatology
2007;45(2):200-202
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Intravenous immunoglobulin therapy has been used to treat various immune-mediated diseases. Its utility in dermatology continues to expand, including treatment for autoimmune blistering disease, graft-versus-host disease, and dermatomyositis. It is generally considered safe, and serious adverse effects such as anaphylaxis, renal tubular necrosis or aseptic meningitis rarely occur. Furthermore, adverse skin reactions very rarely occur, but can include urticaria, pruritus, eczema, alopecia, lichenoid dermatitis or pompholyx. We describe a case of a 48-year-old man who developed vesicular eczema on his palms and soles after administration of intravenous immunoglobulin therapy for encephalomyelopathy.
